Tetrazole Analogues of Aspartic, Glutamic and alfa-Aminoadipic Acids and Their Derivatives with Tetrazole Ring in Side Chains Useful for Solid-Phase Peptide Synthesis

• Autorzy: Manturewicz M. , Grzonka Z.
• Języki publikacji: EN

Abstrakty

EN

Tetrazole analogues of Fmoc-as partic, -glutamic and -alfa-aminoadipic acids with acidic tetrazolyl group inside chains suitable for solid-phase peptide synthesis were obtained. More over, the appropriate derivatives of as partic and glutamic acids containing tetrazole ring methylated in position N1 or N2 were synthesized as well.

Słowa kluczowe

EN

tetrazole analogues of aspartic; glutamic and a-aminoadipic acids; isosters of carboxylic acids; esters and amides

• Wydawca: Polskie Towarzystwo Chemiczne
• Czasopismo: Polish Journal of Chemistry
• Rocznik: 2007
• Tom: Vol. 81, nr 12
• Strony: 2121--2131
• Opis fizyczny: Bibliogr. 20 poz., rys.

Twórcy

autor

Manturewicz M.

autor

Grzonka Z.

• Faculty of Chemistry, University of Gdańsk, ul. J. Sobieskiego 18, 80-952 Gdańsk, Poland Tel.: [phone]; Fax: [phone],

Bibliografia

• 1. Casini A., Scozzafava A., Mastrolorenzo A. and Supuran C.T., Curr. Cancer Drug Targets, 2,55 (2002).
• 2. Scozzafava A., Casini A. and Supuran C.T., Curr. Med Chem., 9, 1167 (2002).
• 3. Supuran C.T., Casini A. and Scozzafava A., Med Res. Rev., 23, 535 (2003).
• 4. Scozzafava A., Owa T., Mastrolorenzo A. and Supuran C.T., Curr. Med Chem., 10, 925 (2003).
• 5. Brzozowski Z., Acta Polon. Pharm. Drug Res., 52, 91 (1995).
• 6. Brzozowski Z., Acta Polon. Pharm. Drug Res., 52, 287 (1995).
• 7. Brzozowski Z., Acta Polon. Pharm. Drug Res., 53, 269 (1996).
• 8. Brzozowski Z., Acta Polon. Pharm. Drug Res., 55, 375 (1998).
• 9. Brzozowski Z. and Kórnicka A., Acta Polon. Pharm. Drug Res., 56, 135 (1999).
• 10. Brzozowski Z., Sączewski F. and Gdaniec M., Eur. J. Med Chem., 37, 285 (2002).
• 11. Sławiński J. and Gdaniec M., Eur. J. Med Chem., 40, 377 (2005).
• 12. Sławiński J. and Brzozowski Z., Eur. J. Med Chem., 41, 1180 (2006).
• 13. Neamati N., Mazumder A., Sunder S., Owen J.H., Schultz R.J. and Pommier Y., Antiviral Chem. Chemother.,8,485(1997).
• 14. Brzozowski Z., Acta Polon. Pharm. Drug Res., 55, 473 (1998).
• 15. Kuo Ch.L., Assefa H., Brzozowski Z., Sławiński J., Sączewski F., Buolamwini J.K. and Neamati N., J. Med Chem., 47, 385 (2004).
• 16. Brzozowski Z., Sączewski F. and Gdaniec M., Bioorg. Med Chem., 11, 3673 (2003).
• 17. Brzozowski Z., Sączewski F. and Gdaniec M., Eur J. Med. Chem., 38, 991 (2003).
• 18. Brzozowski Z., Acta Polon. Pharm. Drug Res., 54, 293 (1997).
• 19. Brzozowski Z. and Sączewski F., J. Med. Chem., 45, 430 (2002).
• 20. Brzozowski Z., Sączewski F. and Neamati N., Bioorg. Med Chem., 14, 2985 (2006).
• 21. Pomarnacka E., Kórnicka A. and Sączewski F., Heterocycles, 55, 753 (2001).
• 22. Brzozowski Z., Sączewski F., Sanchez T., Kuo Ch.L., Gdaniec M. and Neamati N., Bioorg. Med. Chem., 12, 3663 (2004).
• 23. Brzozowski Z., Sączewski F. and Neamati N., Bioorg. Med. Chem. Lett., 16, 5298 (2006).
• 24. Brzozowski Z. and Sławiński J., Acta Polon. Pharm., 41, 133 (1984).
• 25. Krubsack A.J. and Higa T., Tetrahedron Lett., 49, 5149 (l968).
• 26. Cushman M. and Cheng L., J. Org. Chem., 43, 3781 (1978).
• 27. The geometry of 4 was fully optimized using a semi empirical AM1 method. The calculations were carried out using the Spartan Pro program version 1,0,5 (2000), distributed by Waverunction Inc.
• 28. Boyd M.R., Am. Assoc. Cancer Res., 30, 652 (1989).
• 29. Monks A.P., Scudiero D.A., Skehan R, Shoemaker R., Poull K.D., Vistica D., Hose C., Langley J.,Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Cambell H., Mayo J. and Boyd M.J., J. Natl. Cancer Inst., 83, 757 (1991).
• 30. Weinstein J.N., Myers T.G., O'Connor P.M., Friend S.H., Fornance A.J.Jr., Kohn K.W., Fojo T., Bates S.E., Rubinstein L.V., Andersen N.L., Buolamwini J.K., van Osdol W.W., Monks A.P., Scudiero D.A., Sausiville E.A., Zaharevitz D. W., Bunow B., Viswanadhan V.N., Johnson G.S., Wittes R.E. and Paull K.D., Science, 275, 343 (1991).